Search alternatives:
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
1 0 » 1 10 (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
1 0 » 1 10 (Expand Search)
-
301
-
302
-
303
Table_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
304
Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
305
Image_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
306
Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
307
Table_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
308
Image_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
309
Table_3_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. …”
-
310
-
311
-
312
-
313
-
314
-
315
-
316
-
317
Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol expo...
Published 2020“…Prior isoflurane exposure <i>in vitro</i> even increased protection (RIPC-EVs/control, apoptotic ratio: 0.79; p = 0.0035; Sham-EVs/control, apoptotic ratio:1.04) while propofol (50μM) abrogated protection by RIPC-EVs (RIPC-EVs/control, Apoptotic ratio: 1.01; Sham-EVs/control, apoptotic ratio: 0.94; p = 0.602). …”
-
318
-
319
-
320